Bridging cholinergic signalling and inflammation in schizophrenia
Christine N Metz1,2,3, Michael Brines1, Valentin A Pavlov4,5,6
1The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, 11030, USA.
No abstract available in PubMed .
More Related Videos
06:43Increased Recovery Time and Decreased LPS Administration to Study the Vagus Nerve Stimulation Mechanisms in Limited Inflammatory Responses
Published on: March 29, 2017
09:19Improved 3D Hydrogel Cultures of Primary Glial Cells for In Vitro Modelling of Neuroinflammation
Published on: December 8, 2017
Related Concept Videos
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Parasympathetic Signaling
The effects of...
Direct-Acting Cholinergic Agonists: Pharmacological Actions
Ligand-Gated Ion Channel Receptor: Gating Mechanism
